A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy.
Krassnig S, Wohlrab C, Golob-Schwarzl N, Raicht A, Schatz C, Birkl-Toeglhofer AM, Skofler C, Gantenbein N, Leoni M, Asslaber M, Leber SL, Mahdy-Ali K, von Campe G, Mayer M, Borenich A, Weis S, Benesch M, Haybaeck J.
Krassnig S, et al. Among authors: borenich a.
Cancers (Basel). 2021 Mar 23;13(6):1482. doi: 10.3390/cancers13061482.
Cancers (Basel). 2021.
PMID: 33807050
Free PMC article.